Healio

Testosterone cream may provide ‘new pathway’ to treat recalcitrant MGD

Please provide your email address to receive an email when new articles are posted on . Meibomian gland dysfunction symptoms, including secretions and visual acuity, improved with the use of ...
Morningstar

Aviva Bio Announces FDA Guidance on Development Pathway for Women’s Testosterone Therapy and New Evidence of a Reduced Risk of Breast Cancer Cell Proliferation for AVA-291

In its feedback, the FDA acknowledged the potential breast cancer risk associated with T use in women—a central safety issue that has historically limited the development of a T therapy for women.
Business Wire

Aviva Bio Announces FDA Guidance on Development Pathway for Women’s Testosterone Therapy.

In its feedback, the FDA acknowledged the potential breast cancer risk associated with T use in women—a central safety issue that has historically limited the development of a T therapy for women.